Physician

Jitendra I Vasandani, MD

According to 2025 Medicare claims, Jitendra Vasandani, MD (NPI: 1194707406) practices rheumatology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-TX PLLC (NPI: 1639521859; TIN: 812174373) and primary practice location at 79424-6153. Vasandani is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Vasandani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 312,742 HCPCS/CPT codes, and received $3,555,629 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,292 prescription claims across 942 beneficiaries totaling $3,199,188 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 484 records totaling $1,002,994. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,039,966 and ending at $3,555,629. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $1,039,966 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $209,094 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $235,175 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $171,886 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $528,679 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $100,767 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $257,578 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $327,751 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,457,370 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,555,629 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015855137,984$1,039,966
20169705,665$209,094
20171,1035,539$235,175
20181,0133,674$171,886
20197734,664$528,679
20204626,068$100,767
202142816,043$257,578
202240619,685$327,751
2023977205,426$2,457,370
20241,001312,742$3,555,629

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.9M$12M2015 Drug cost: $3,190,549 (USD; Tot_Drug_Cst)2016 Drug cost: $4,738,052 (USD; Tot_Drug_Cst)2017 Drug cost: $6,079,232 (USD; Tot_Drug_Cst)2018 Drug cost: $7,861,238 (USD; Tot_Drug_Cst)2019 Drug cost: $11,748,626 (USD; Tot_Drug_Cst)2020 Drug cost: $10,055,761 (USD; Tot_Drug_Cst)2021 Drug cost: $6,160,594 (USD; Tot_Drug_Cst)2022 Drug cost: $6,017,087 (USD; Tot_Drug_Cst)2023 Drug cost: $5,098,888 (USD; Tot_Drug_Cst)2024 Drug cost: $3,199,188 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201597314,323$3,190,549
20161,12014,981$4,738,052
20171,24715,087$6,079,232
20181,37715,829$7,861,238
20191,50416,031$11,748,626
20201,54614,547$10,055,761
20211,4769,237$6,160,594
20221,2689,672$6,017,087
20231,1586,556$5,098,888
20249425,292$3,199,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more167167$103
96413Administration of chemotherapy into vein, 1 hour or less122721$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more9642,206$84
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle1671,218$51
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's7021,140$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept752,128$565,739
Humira(Cf) PenAdalimumab561,568$367,905
SimponiGolimumab461,336$282,605
TremfyaGuselkumab151,008$245,616
BenlystaBelimumab381,072$186,252

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.268$6,625Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.216$996,369SUN PHARMACEUTICAL INDUSTRIES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jitendra I. Vasandani, MD?

Tedicare shows public-source Medicare data for Jitendra I. Vasandani, MD (NPI 1194707406), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jitendra I. Vasandani, MD have ACO affiliation data?

Jitendra I. Vasandani, MD is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jitendra I. Vasandani, MD?

Jitendra I. Vasandani, MD is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-TX PLLC (billing NPI 1639521859) in the available physician profile data.

Does Jitendra I. Vasandani, MD have Open Payments data?

Jitendra I. Vasandani, MD has 484 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.